Connecticut 2018 Regular Session

Connecticut Senate Bill SB00483

Introduced
3/12/18  
Introduced
3/12/18  
Refer
3/12/18  
Refer
3/12/18  
Report Pass
3/28/18  
Report Pass
3/28/18  
Refer
4/9/18  
Refer
4/9/18  
Report Pass
4/16/18  
Report Pass
4/16/18  
Engrossed
5/4/18  
Report Pass
5/6/18  
Chaptered
5/30/18  
Enrolled
6/1/18  
Passed
6/14/18  

Caption

An Act Concerning The Prevention And Treatment Of Opioid Dependency And Opioid Overdoses In The State.

Impact

The bill also includes provisions for revising the methods for prescribing controlled substances, focusing on creating more supportive environments for medication-assisted treatments like methadone. Additionally, it encourages the Departments of Correction and Mental Health to seek federal funding to expand treatment programs in correctional facilities. Importantly, the legislation may lead to an overall reduction in opioid-related deaths by increasing access to effective treatments and establishing better monitoring systems for those in recovery.

Summary

Senate Bill 00483, also known as the Act Concerning The Prevention And Treatment Of Opioid Dependency And Opioid Overdoses In The State, aims to address the rising concerns surrounding opioid addiction and overdose recoveries within the state. This bill proposes several measures including establishing specialized courts for opioid-dependent individuals who might benefit from intensive monitoring and treatment, rather than traditional punitive measures. It recognizes the need for reform in judicial processes to better cater to the treatment needs of affected individuals, promoting rehabilitation over punishment.

Sentiment

Overall, the sentiment surrounding SB00483 has been overwhelmingly positive among health advocates and lawmakers focused on combating the opioid crisis. There is a recognition of the critical need for adaptable and responsive legal frameworks that prioritize public health and recovery. However, discussions have highlighted a few points of contention regarding the balance of judicial oversight and the extent to which a rehabilitative approach should be prioritized over punitive measures for drug offenses.

Contention

Notable points of contention include discussions about the potential challenges in implementing specialized courts and ensuring sufficient resources for treatment programs. Critics may argue about the feasibility of maintaining intensive court monitoring while providing adequate treatment options within a globally constrained budget. Moreover, questions have been raised regarding the responsibilities of different state departments in executing the proposed reforms and whether these changes will bring about substantial improvements in an already strained public health system.

Companion Bills

No companion bills found.

Previously Filed As

CT SB00274

An Act Concerning Opioids.

CT HB05249

An Act Concerning Personal Opioid Drug Deactivation And Disposal Systems And The Opioid Settlement Fund.

CT HB05511

An Act Concerning The Opioid Settlement Advisory Committee.

CT SB00154

An Act Concerning Various And Assorted Revisions To The Education Statutes.

CT HB05508

An Act Concerning Recommendations From The Juvenile Justice Policy And Oversight Committee.

CT SB00001

An Act Concerning The Health And Safety Of Connecticut Residents.

CT HB05291

An Act Concerning The Department Of Public Health's Recommendations Regarding Improved Opioid Monitoring.

CT HB05422

An Act Concerning Hate And Bias Crimes.

CT HB05348

An Act Concerning Paraeducators.

CT SB00212

An Act Concerning The Revisor's Technical Corrections To The General Statutes.

Similar Bills

CT SB00431

An Act Concerning Changes To Prescription Drug Abuse Statutes.

CT HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

CA AB1037

Public health: substance use disorder.

VA HB1511

Midwifery; administration of medication.

VA HB2497

Midwifery; administration of medication within scope of practice.

CT HB05430

An Act Concerning Opioids.

CT HB06856

An Act Concerning Substance Abuse And Opioid Overdose Prevention.

WV SB2028

Permitting development of opioid treatment program if part of clinical trial and approved by institutional review board